Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

Germany: Grünenthal acquires cancer treatment from Bayer AG for up to €375m

Debt Nick Herbert -
Grünenthal, a Germany-headquartered global pharma focused on pain management, has agreed to acquire Stivarga, an oral treatment for specific advanced cancers, from Bayer AG for up to €375m (US$430m). Stivarga (regorafenib) is an oral multkinase inhibitor indicated for metastatic colorectal cancer, hepatocellular carcinoma and gastrointestinal stromal tumours (GIST) in patients...

Denmark: Ambu takes next step in reaching leading position in global endoscopy with TIMS Medical acquisition

Life Sciences Nick Herbert -
Ambu, a Denmark-based listed global MedTech company that delivers solutions in endoscopy, anesthesia, and patient monitoring, has acquired TIMS Medical (a division of Foresight Imaging), a US-based MedTech company specialising in imaging and reporting solutions, for an upfront payment of US$45m and additional milestone payments of up to US$20m. The acquisition is a strategic step in Ambu’s aspiration to achieve a leading position in global endoscopy. “TIMS Medical has built an impressive platform that is deeply embedded in clinical workflows across the US,” said Britt Meelby Jensen, CEO of Ambu. “By combining...